Etanercept of greater value than adalimumab or infliximab for RA Clinical study 09 February 2013 Pages: 2 - 2
Routine rotavirus vaccination realises results in Germany Clinical study 09 February 2013 Pages: 5 - 5
Eprosartan worth it in hypertension + cerebrovascular disease Clinical study 09 February 2013 Pages: 8 - 8
Development of a coordinated statewide system for STEMI* reperfusion achieved substantial improvements in quality of care, Clinical study 09 February 2013 Pages: 9 - 9
Sunitinib potentially cost effective for metastatic renal cancer Clinical study 09 February 2013 Pages: 9 - 9
Updated guidelines on the use of erythropoietin-stimulating agents have been released Media release 09 February 2013 Pages: 10 - 10
Guideline-indicated life-saving medical and device therapies are considerably underutilised in outpatients with heart failure Media release 09 February 2013 Pages: 10 - 10
No bones about the cost effectiveness of zoledronic acid Meeting report 09 February 2013 Pages: 11 - 12
Despite guidelines recommending intensive lipid-lowering therapy in patients with ACS,* most such patients do not receive such treatment, Clinical study 09 February 2013 Pages: 12 - 12
Stepped protocol STITCHes up standard practice in hypertension News item 09 February 2013 Pages: 14 - 14
The growth of the global pharmaceutical market is expected to slow in 2008, Media release 09 February 2013 Pages: 15 - 15